Reed Elsevier (LON: REL) had its target price increased by JPMorgan Chase from $10.30 (690 GBX) to $11.95 (800 GBX) in a report issued on Friday. They currently have an overweight rating on the stock.

A number of other analysts have also recently weighed in on REL. Analysts at JP Morgan Cazenove cut their price target on shares of Reed Elsevier from $11.95 to $10.30 in a research note to investors on Thursday, March 7th. They now have an overweight rating on the stock. Separately, analysts at Jefferies Group reiterated a buy rating on shares of Reed Elsevier in a research note to investors on Thursday, February 28th. They now have a $11.41 price target on the stock. Finally, analysts at Investec Securities reiterated a buy rating on shares of Reed Elsevier in a research note to investors on Thursday, February 28th. They now have a $11.71 price target on the stock.

Reed Elsevier traded up 0.95% on Friday, hitting GBX 741.00. Reed Elsevier has a 52-week low of GBX 466.10 and a 52-week high of GBX 742.00. The stock’s 50-day moving average is currently GBX 599.8. The company’s market cap is £8.793 billion.

Reed Elsevier PLC is a provider of professional information solutions. As of December 31, 2011, the Company was organized in five business segments: Elsevier, providing scientific, technical and medical information solutions; LexisNexis Risk Solutions, providing risk information and analytics to business and government customers; LexisNexis Legal & Professional, providing legal, tax, regulatory and business information solutions to professionals, business and government customers; Reed Exhibitions, organising trade exhibitions and conferences, and Reed Business Information, providing information and marketing solutions to business professionals.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.